Short description
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Description
Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders.
Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 1978
Exited on
September 27, 1991
Went public on
September 27, 1991
Stock symbol
BIIB
Non-profit?
No
Acquired?
No
Revenue range
$1230 - 4560
Sign in for full access
Investors
Blurry Noaccess
Sign in for full access
Founders
Bernard Mach, Jeff Behrens, Phillip Sharp
Funding rounds count
29
Portfolio organisations count
Noaccess, No Way
Sign in for full access
Lead investments count
8
Exits count
Blurry Noaccess, Noaccess
Sign in for full access
IPO exits count
17